These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 19254517

  • 1. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
    Gentile S, Bellantuono C.
    J Clin Psychiatry; 2009 Mar; 70(3):414-22. PubMed ID: 19254517
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [Abstract] [Full Text] [Related]

  • 3. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
    Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Bérard A, Koren G.
    Clin Ther; 2007 May; 29(5):918-926. PubMed ID: 17697910
    [Abstract] [Full Text] [Related]

  • 4. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
    Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D.
    Birth Defects Res B Dev Reprod Toxicol; 2007 Feb; 80(1):18-27. PubMed ID: 17187388
    [Abstract] [Full Text] [Related]

  • 5. Publishing statistically significant results with questionable clinical importance: focus on antidepressant use in pregnancy.
    Einarson A.
    J Clin Psychiatry; 2012 Nov; 73(11):1443-6. PubMed ID: 23218161
    [No Abstract] [Full Text] [Related]

  • 6. SSRI antidepressants and birth defects.
    Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
    [Abstract] [Full Text] [Related]

  • 7. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
    Diav-Citrin O, Shechtman S, Weinbaum D, Wajnberg R, Avgil M, Di Gianantonio E, Clementi M, Weber-Schoendorfer C, Schaefer C, Ornoy A.
    Br J Clin Pharmacol; 2008 Nov; 66(5):695-705. PubMed ID: 18754846
    [Abstract] [Full Text] [Related]

  • 8. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.
    Nordeng H, van Gelder MM, Spigset O, Koren G, Einarson A, Eberhard-Gran M.
    J Clin Psychopharmacol; 2012 Apr; 32(2):186-94. PubMed ID: 22367660
    [Abstract] [Full Text] [Related]

  • 9. Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
    Prescrire Int; 1999 Oct; 8(43):157-9. PubMed ID: 11503843
    [Abstract] [Full Text] [Related]

  • 10. Antidepressant use in pregnancy: a critical review focused on risks and controversies.
    Byatt N, Deligiannidis KM, Freeman MP.
    Acta Psychiatr Scand; 2013 Feb; 127(2):94-114. PubMed ID: 23240634
    [Abstract] [Full Text] [Related]

  • 11. Clinical management of perinatal depression: focus on paroxetine.
    Newport DJ, Stowe ZN.
    Psychopharmacol Bull; 2003 Feb; 37 Suppl 1():148-66. PubMed ID: 14566197
    [Abstract] [Full Text] [Related]

  • 12. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects.
    Gentile S.
    Acta Psychiatr Scand; 2011 Apr; 123(4):266-75. PubMed ID: 21261600
    [Abstract] [Full Text] [Related]

  • 13. Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
    Tuccori M, Montagnani S, Testi A, Ruggiero E, Mantarro S, Scollo C, Pergola A, Fornai M, Antonioli L, Colucci R, Corona T, Blandizzi C.
    Postgrad Med; 2010 Jul; 122(4):49-65. PubMed ID: 20675971
    [Abstract] [Full Text] [Related]

  • 14. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B.
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [Abstract] [Full Text] [Related]

  • 15. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.
    Bérard A, Iessa N, Chaabane S, Muanda FT, Boukhris T, Zhao JP.
    Br J Clin Pharmacol; 2016 Apr; 81(4):589-604. PubMed ID: 26613360
    [Abstract] [Full Text] [Related]

  • 16. [SSRIs and pregnancy: a review of the literature].
    Soufia M, Aoun J, Gorsane MA, Krebs MO.
    Encephale; 2010 Dec; 36(6):513-6. PubMed ID: 21130237
    [Abstract] [Full Text] [Related]

  • 17. Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?
    Haddad PM, Pal BR, Clarke P, Wieck A, Sridhiran S.
    J Psychopharmacol; 2005 Sep; 19(5):554-7. PubMed ID: 16166193
    [Abstract] [Full Text] [Related]

  • 18. Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome.
    Malm H.
    Ther Drug Monit; 2012 Dec; 34(6):607-14. PubMed ID: 23042258
    [Abstract] [Full Text] [Related]

  • 19. An imperfect literature and evidence-based medicine.
    Freeman MP.
    J Clin Psychiatry; 2009 Mar; 70(3):412-3. PubMed ID: 19317958
    [No Abstract] [Full Text] [Related]

  • 20. Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.
    Gentile S.
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(10):1585-97. PubMed ID: 26135630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.